Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 313

1.

Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategies.

He MY, Rancoule C, Rehailia-Blanchard A, Espenel S, Trone JC, Bernichon E, Guillaume E, Vallard A, Magné N.

Crit Rev Oncol Hematol. 2018 Nov;131:96-101. doi: 10.1016/j.critrevonc.2018.09.004. Epub 2018 Sep 12. Review.

PMID:
30293712
2.

Intensification of induction chemotherapy before consolidation chemoradiotherapy improves progression-free survival and time without treatment in patients with locally advanced pancreatic cancers.

Williet N, Di Bernardo T, Vernet C, Roche LS, Muron T, Roblin X, Magne N, Phelip JM.

Oncotarget. 2018 Aug 10;9(62):31999-32009. doi: 10.18632/oncotarget.25877. eCollection 2018 Aug 10.

3.

[Reprint of: Treatment of patients with inoperable stage III or stage IV melanoma. Société française de dermatologie].

Guillot B, Charles J, Jeudy G, Cupissol D, Dupuy A, Dutriaux C, Gangloff D, Magne N, Mirabel X, M'Sadek A, Pracht M, Sichel C, Do Outeiro G.

Bull Cancer. 2018 Sep;105(9):780-789. doi: 10.1016/j.bulcan.2018.06.002. Epub 2018 Aug 14. French. No abstract available.

PMID:
30115366
4.

Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey.

Langrand-Escure J, Diao P, Garcia MA, Wang G, Guy JB, Espenel S, Guillaume E, Rehailia-Blanchard A, Pigné G, de Laroche G, Kaczmarek D, Muron T, Porcheron J, Phelip JM, Vallard A, Magné N.

Sci Rep. 2018 Jul 16;8(1):10708. doi: 10.1038/s41598-018-29040-2.

5.

Harnessing drug/radiation interaction through daily routine practice: Leverage medical and methodological point of view (MORSE 02-17 study).

Vallard A, Rancoule C, Espenel S, Garcia MA, Langrand-Escure J, He MY, Ben Mrad M, El Meddeb Hamrouni A, Ouni S, Trone JC, Rehailia-Blanchard A, Guillaume E, Vial N, Riocreux C, Guy JB, Magné N.

Radiother Oncol. 2018 Jun 21. pii: S0167-8140(18)30310-4. doi: 10.1016/j.radonc.2018.06.010. [Epub ahead of print]

PMID:
29937210
6.

Spinal meningioma and factors predictive of post-operative deterioration.

Gilard V, Goia A, Ferracci FX, Marguet F, Magne N, Langlois O, Perez A, Derrey S.

J Neurooncol. 2018 Oct;140(1):49-54. doi: 10.1007/s11060-018-2929-y. Epub 2018 Jun 20.

PMID:
29926318
7.

Outcomes prediction in pre-operative radiotherapy locally advanced rectal cancer: leucocyte assessment as immune biomarker.

Vallard A, Garcia MA, Diao P, Espenel S, de Laroche G, Guy JB, Mrad MB, Rancoule C, Kaczmarek D, Muron T, Pigné G, Porcheron J, Peoc'h M, Phelip JM, Langrand-Escure J, Magné N.

Oncotarget. 2018 Apr 27;9(32):22368-22382. doi: 10.18632/oncotarget.25023. eCollection 2018 Apr 27.

8.

Pharmacological modulation of radiation-induced oral mucosal complications.

Bockel S, Vallard A, Lévy A, François S, Bourdis M, Le Gallic C, Riccobono D, Annede P, Drouet M, Tao Y, Blanchard P, Deutsch É, Magné N, Chargari C.

Cancer Radiother. 2018 Sep;22(5):429-437. doi: 10.1016/j.canrad.2017.11.006. Epub 2018 May 26. Review.

PMID:
29776830
9.

Primary bacterial ventriculitis in adults, an emergent diagnosis challenge: report of a meningoccal case and review of the literature.

Lesourd A, Magne N, Soares A, Lemaitre C, Taha MK, Gueit I, Wolff M, Caron F.

BMC Infect Dis. 2018 May 18;18(1):226. doi: 10.1186/s12879-018-3119-4.

10.

Biological aspects of chondrosarcoma: Leaps and hurdles.

Mery B, Espenel S, Guy JB, Rancoule C, Vallard A, Aloy MT, Rodriguez-Lafrasse C, Magné N.

Crit Rev Oncol Hematol. 2018 Jun;126:32-36. doi: 10.1016/j.critrevonc.2018.03.009. Epub 2018 Mar 22. Review.

PMID:
29759564
11.

[Oligometastatic breast cancer : therapeutic implications of a new paradigm].

Méry B, Moriceau G, Vallard A, Jacquin JP, Magné N.

Rev Med Brux. 2018;39(2):111-113. doi: 10.30637/2018.16-054. French.

PMID:
29722493
12.

[Treatment of patients with inoperable stage III or stage IV melanoma. Société française de dermatologie].

Guillot B, Charles J, Jeudy G, Cupissol D, Dupuy A, Dutriaux C, Gangloff D, Magne N, Mirabel X, M'Sadek A, Pracht M, Sichel C, Do Outeiro G.

Ann Dermatol Venereol. 2018 Jun - Jul;145(6-7):413-422. doi: 10.1016/j.annder.2018.03.165. Epub 2018 Apr 25. French. No abstract available.

PMID:
29703640
13.

Evaluation of the quality of the reporting of phase II clinical trials in oncology: A systematic review.

Rivoirard R, Langrand-Escure J, Oriol M, Tinquaut F, Chauvin F, Rancoule C, Magné N, Bourmaud A.

Crit Rev Oncol Hematol. 2018 May;125:78-83. doi: 10.1016/j.critrevonc.2018.02.014. Epub 2018 Mar 10. Review.

PMID:
29650280
14.

Comprehensive Geriatric Assessment and quality of life after localized prostate cancer radiotherapy in elderly patients.

Goineau A, Campion L, d'Aillières B, Vié B, Ghesquière A, Béra G, Jaffres D, de Laroche G, Magné N, Artignan X, Chamois J, Bergerot P, Martin E, Créhange G, Deniaud-Alexandre E, Buthaud X, Belkacémi Y, Doré M, de Decker L, Supiot S.

PLoS One. 2018 Apr 9;13(4):e0194173. doi: 10.1371/journal.pone.0194173. eCollection 2018.

15.

Correction to: From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience.

Espenel S, Garcia MA, Trone JC, Guillaume E, Harris A, Rehailia-Blanchard A, He MY, Ouni S, Vallard A, Rancoule C, Mrad MB, Chauleur C, De Laroche G, Guy JB, Moreno-Acosta P, Magné N.

Radiat Oncol. 2018 Mar 23;13(1):50. doi: 10.1186/s13014-018-0999-9.

16.

Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events-a meta-analysis.

Trone JC, Ollier E, Chapelle C, Bertoletti L, Cucherat M, Mismetti P, Magné N, Laporte S.

Ann Oncol. 2018 Apr 1;29(4):803-811. doi: 10.1093/annonc/mdy035.

PMID:
29415169
17.

Radiotherapy of rectal cancer in elderly patients: Real-world data assessment in a decade.

Diao P, Langrand-Escure J, Garcia MA, Espenel S, Rehailia-Blanchard A, de Lavigerie B, Vial N, de Laroche G, Vallard A, Magné N.

Dig Liver Dis. 2018 Jun;50(6):608-616. doi: 10.1016/j.dld.2018.01.122. Epub 2018 Mar 1.

PMID:
29409780
18.

Comparison of enhancement of the vestibular perilymph between gadoterate meglumine and gadobutrol at 3-Tesla in Meniere's disease.

Eliezer M, Poillon G, Gillibert A, Horion J, Cruypeninck Y, Gerardin E, Magne N, Attyé A.

Diagn Interv Imaging. 2018 May;99(5):271-277. doi: 10.1016/j.diii.2018.01.002. Epub 2018 Feb 15.

PMID:
29398574
19.

From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience.

Espenel S, Garcia MA, Trone JC, Guillaume E, Harris A, Rehailia-Blanchard A, He MY, Ouni S, Vallard A, Rancoule C, Ben Mrad M, Chauleur C, De Laroche G, Guy JB, Moreno-Acosta P, Magné N.

Radiat Oncol. 2018 Feb 2;13(1):16. doi: 10.1186/s13014-018-0963-8. Erratum in: Radiat Oncol. 2018 Mar 23;13(1):50.

20.

A retrospective survey of the last 3 months of life in patients carrying glioblastoma: Clinical treatments and profiles.

Rivoirard R, Vallard A, Boutet C, Falk AT, Garin C, Adjabi A, Hoarau D, Forest F, Fotso MJ, Rancoule C, Magné N.

Mol Clin Oncol. 2018 Jan;8(1):115-120. doi: 10.3892/mco.2017.1479. Epub 2017 Nov 2.

21.

Evaluation of the Cell Invasion and Migration Process: A Comparison of the Video Microscope-based Scratch Wound Assay and the Boyden Chamber Assay.

Guy JB, Espenel S, Vallard A, Battiston-Montagne P, Wozny AS, Ardail D, Alphonse G, Rancoule C, Rodriguez-Lafrasse C, Magne N.

J Vis Exp. 2017 Nov 17;(129). doi: 10.3791/56337.

PMID:
29286429
22.

[Hot topics in 2017 in oncology and hematology. A selection by the editorial board of Bulletin du Cancer].

Vignot S, André T, Caux C, Bouleuc C, Evrard S, Gonçalves A, Lacroix M, Magné N, Massard C, Mazeron JJ, Orbach D, Rodrigues M, Thariat J, Wislez M, L'Allemain G, Bay JO.

Bull Cancer. 2018 Jan;105(1):6-14. doi: 10.1016/j.bulcan.2017.11.006. Review. French.

PMID:
29269176
23.

Quality of reporting in oncology phase II trials: A 5-year assessment through systematic review.

Langrand-Escure J, Rivoirard R, Oriol M, Tinquaut F, Rancoule C, Chauvin F, Magné N, Bourmaud A.

PLoS One. 2017 Dec 7;12(12):e0185536. doi: 10.1371/journal.pone.0185536. eCollection 2017.

24.

[Towards a better use of midazolam in end of life: A survey in a department of medical oncology].

Beneton A, Vallard A, Brosse C, Poenou G, Pacaut C, Magné N, Morisson S.

Bull Cancer. 2017 Nov;104(11):929-936. doi: 10.1016/j.bulcan.2017.10.003. Epub 2017 Nov 15. French.

PMID:
29150095
25.

[Impairment of DNA damage response and cancer].

Rancoule C, Vallard A, Guy JB, Espenel S, Sauvaigo S, Rodriguez-Lafrasse C, Magné N.

Bull Cancer. 2017 Nov;104(11):962-970. doi: 10.1016/j.bulcan.2017.09.006. Epub 2017 Nov 11. Review. French.

PMID:
29132683
26.

[Biomarkers of radiation-induced DNA repair processes].

Vallard A, Rancoule C, Guy JB, Espenel S, Sauvaigo S, Rodriguez-Lafrasse C, Magné N.

Bull Cancer. 2017 Nov;104(11):981-987. doi: 10.1016/j.bulcan.2017.09.004. Epub 2017 Nov 10. Review. French.

PMID:
29132682
27.

Healing touch in radiation therapy: is the benefit tangible?

Guy JB, Bard-Reboul S, Trone JC, Vallard A, Espenel S, Langrand-Escure J, Hamrouni A, Mrad MB, Morisson S, Michaud P, Magné N, Rancoule C.

Oncotarget. 2017 Aug 30;8(46):81485-81491. doi: 10.18632/oncotarget.20594. eCollection 2017 Oct 6.

28.

[The 150th anniversary of Marie Curie].

Mazeron JJ, Magné N, Thariat J.

Bull Cancer. 2017 Nov;104(11):912-913. doi: 10.1016/j.bulcan.2017.10.001. Epub 2017 Nov 3. French. No abstract available.

PMID:
29108642
29.

Predictive Factors of Headache Resolution After Chiari Type 1 Malformation Surgery.

Grangeon L, Puy L, Gilard V, Hebant B, Langlois O, Derrey S, Gerardin E, Maltete D, Guegan-Massardier E, Magne N.

World Neurosurg. 2018 Feb;110:e60-e66. doi: 10.1016/j.wneu.2017.10.070. Epub 2017 Oct 21.

PMID:
29066319
30.

Navigating the highlights of phase III trials: a watchful eye on evidence-based radiotherapy.

Trone JC, Espenel S, Rehailia-Blanchard A, Guillaume E, Vial N, Rancoule C, Rodriguez-Lafrasse C, Ben Mrad M, El Meddeb Hamrouni A, Ollier E, Chargari C, Deutsch E, Vallard A, Magné N.

Ann Oncol. 2017 Nov 1;28(11):2691-2697. doi: 10.1093/annonc/mdx347. Review.

PMID:
29045516
31.

Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol.

Bernichon E, Vallard A, Wang Q, Attignon V, Pissaloux D, Bachelot T, Heudel PE, Ray-Coquard I, Bonnet E, de la Fouchardière A, Faure C, Chopin N, Beurrier F, Racadot S, Sunyach MP, Rancoule C, Perol D, Corset V, Agrapart V, Tinquaut F, Blay JY, Magné N, Trédan O.

Ann Oncol. 2017 Nov 1;28(11):2773-2779. doi: 10.1093/annonc/mdx488.

PMID:
28945826
32.

Dual "mAb" HER family blockade in head and neck cancer human cell lines combined with photon therapy.

Guy JB, Méry B, Ollier E, Espenel S, Vallard A, Wozny AS, Simonet S, Lauret A, Battiston-Montagne P, Ardail D, Alphonse G, Rancoule C, Rodriguez-Lafrasse C, Magné N.

Sci Rep. 2017 Sep 22;7(1):12207. doi: 10.1038/s41598-017-12367-7.

33.

Gadolinium-based nanoparticles as sensitizing agents to carbon ions in head and neck tumor cells.

Wozny AS, Aloy MT, Alphonse G, Magné N, Janier M, Tillement O, Lux F, Beuve M, Rodriguez-Lafrasse C.

Nanomedicine. 2017 Nov;13(8):2655-2660. doi: 10.1016/j.nano.2017.07.015. Epub 2017 Aug 2.

PMID:
28779947
34.

Biomarkers of resistance to radiation therapy: a prospective study in cervical carcinoma.

Moreno-Acosta P, Vallard A, Carrillo S, Gamboa O, Romero-Rojas A, Molano M, Acosta J, Mayorga D, Rancoule C, Garcia MA, Cotes Mestre M, Magné N.

Radiat Oncol. 2017 Jul 17;12(1):120. doi: 10.1186/s13014-017-0856-2.

35.

Radiotherapy among nonagenarians with anal or rectal carcinoma: should we avoid or adapt treatment?

Vallard A, Rancoule C, Guy JB, Assouline A, Falk AT, Auberdiac P, Langrand-Escure J, Chargari C, Magné N.

Chin J Cancer. 2017 Jul 14;36(1):56. doi: 10.1186/s40880-017-0224-5. No abstract available.

36.

Brain metastases from non-small cell lung carcinoma: Changing concepts for improving patients' outcome.

Rancoule C, Vallard A, Guy JB, Espenel S, Diao P, Chargari C, Magné N.

Crit Rev Oncol Hematol. 2017 Aug;116:32-37. doi: 10.1016/j.critrevonc.2017.05.007. Epub 2017 May 20. Review.

PMID:
28693798
37.

[Medical prevention and treatment of radiation-induced pulmonary complications].

Vallard A, Rancoule C, Le Floch H, Guy JB, Espenel S, Le Péchoux C, Deutsch É, Magné N, Chargari C.

Cancer Radiother. 2017 Aug;21(5):411-423. doi: 10.1016/j.canrad.2017.03.004. Epub 2017 Jun 5. Review. French.

PMID:
28596060
38.

Comparison of electromagnetic neuronavigation system and free-hand method for ventricular catheter placement in internal shunt.

Gilard V, Magne N, Gerardin E, Curey S, Pelletier V, Hannequin P, Derrey S.

Clin Neurol Neurosurg. 2017 Jul;158:93-97. doi: 10.1016/j.clineuro.2017.05.007. Epub 2017 May 8.

PMID:
28500927
39.

Management and outcome of cerebral venous thrombosis after head trauma: A case series.

Grangeon L, Gilard V, Ozkul-Wermester O, Lefaucheur R, Curey S, Gerardin E, Derrey S, Maltete D, Magne N, Triquenot A.

Rev Neurol (Paris). 2017 Jun;173(6):411-417. doi: 10.1016/j.neurol.2017.03.025. Epub 2017 May 8.

PMID:
28495232
40.

[Immunotherapy: Activation of a system not a pathway].

Bernichon E, Rancoule C, Vallard A, Langrand-Escure J, Mery B, Guy JB, Magné N.

Bull Cancer. 2017 May;104(5):462-475. doi: 10.1016/j.bulcan.2017.03.004. Epub 2017 May 3. Review. French.

PMID:
28477871
41.

In Vitro Cell Death Determination for Drug Discovery: A Landscape Review of Real Issues.

Méry B, Guy JB, Vallard A, Espenel S, Ardail D, Rodriguez-Lafrasse C, Rancoule C, Magné N.

J Cell Death. 2017 Feb 24;10:1179670717691251. doi: 10.1177/1179670717691251. eCollection 2017. Review.

42.

Long-Lasting Cerebral Vasospasm, Microthrombosis, Apoptosis and Paravascular Alterations Associated with Neurological Deficits in a Mouse Model of Subarachnoid Hemorrhage.

El Amki M, Dubois M, Lefevre-Scelles A, Magne N, Roussel M, Clavier T, Guichet PO, Gérardin E, Compère V, Castel H.

Mol Neurobiol. 2018 Apr;55(4):2763-2779. doi: 10.1007/s12035-017-0514-6. Epub 2017 Apr 28.

PMID:
28455691
43.

Venous thromboembolism in radiation therapy cancer patients: Findings from the RIETE registry.

Guy JB, Bertoletti L, Magné N, Rancoule C, Mahé I, Font C, Sanz O, Martín-Antorán JM, Pace F, Vela JR, Monreal M; RIETE investigators.

Crit Rev Oncol Hematol. 2017 May;113:83-89. doi: 10.1016/j.critrevonc.2017.03.006. Epub 2017 Mar 9.

PMID:
28427527
44.

The world of targeted therapies in kidney cancers: pitfalls, tips and tricks.

Vallard A, Trone JC, Langrand-Escure J, Espenel S, Guy JB, Rancoule C, Xia Y, El Meddeb Hamrouni A, Ben Mrad M, Magné N.

Onco Targets Ther. 2017 Mar 3;10:1375-1380. doi: 10.2147/OTT.S127919. eCollection 2017.

45.

Differential pattern of HIF-1α expression in HNSCC cancer stem cells after carbon ion or photon irradiation: one molecular explanation of the oxygen effect.

Wozny AS, Lauret A, Battiston-Montagne P, Guy JB, Beuve M, Cunha M, Saintigny Y, Blond E, Magne N, Lalle P, Ardail D, Alphonse G, Rodriguez-Lafrasse C.

Br J Cancer. 2017 May 9;116(10):1340-1349. doi: 10.1038/bjc.2017.100. Epub 2017 Apr 13.

46.

Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index.

Rancoule C, Espenel S, Trone JC, Langrand-Escure J, Vallard A, Rehailia-Blanchard A, El Meddeb Hamrouni A, Xia Y, Guy JB, Ben-Mrad M, Magné N.

Oncotarget. 2017 Jun 27;8(26):43543-43554. doi: 10.18632/oncotarget.16672. Review.

47.

Atrial fibrillation in cancer patients: Hindsight, insight and foresight.

Mery B, Guichard JB, Guy JB, Vallard A, Barthelemy JC, Da Costa A, Magné N, Bertoletti L.

Int J Cardiol. 2017 Aug 1;240:196-202. doi: 10.1016/j.ijcard.2017.03.132. Epub 2017 Apr 6. Review.

PMID:
28390744
48.

[Atypical presentation of a breast cancer pituitary metastasis].

Langrand-Escure J, Vallard A, Suchaud JP, Diao P, Magné N.

Rev Med Liege. 2016 Jul;71(7-8):332-335. French.

49.

HPV-16 variants' impact on uterine cervical cancer response to radiotherapy: A descriptive pilot study.

Moreno-Acosta P, Vallard A, Molano M, Huertas A, Gamboa Ó, Cotes M, Romero-Rojas A, Rancoule C, Magné N.

Cancer Radiother. 2017 Apr;21(2):104-108. doi: 10.1016/j.canrad.2016.09.018. Epub 2017 Mar 18.

PMID:
28325620
50.

Quality of reporting in oncology studies: A systematic analysis of literature reviews and prospects.

Rivoirard R, Bourmaud A, Oriol M, Tinquaut F, Méry B, Langrand-Escure J, Vallard A, Fournel P, Magné N, Chauvin F.

Crit Rev Oncol Hematol. 2017 Apr;112:179-189. doi: 10.1016/j.critrevonc.2017.02.012. Epub 2017 Feb 24. Review.

PMID:
28325258

Supplemental Content

Support Center